Maravai LifeSciences
MRVI
MRVI
206 hedge funds and large institutions have $1.06B invested in Maravai LifeSciences in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 72 increasing their positions, 70 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
5% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 43
2% less funds holding
Funds holding: 210 → 206 (-4)
10% less capital invested
Capital invested by funds: $1.18B → $1.06B (-$122M)
Holders
206
Holding in Top 10
2
Calls
$1.51M
Puts
$208K
Top Buyers
| 1 | +$29.8M | |
| 2 | +$23.7M | |
| 3 | +$15.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$12.9M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$14.7M | |
| 3 | -$11M | |
| 4 |
D.E. Shaw & Co
New York
|
-$8.02M |
| 5 |
Morgan Stanley
New York
|
-$6.33M |